| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.
|
Eur Heart J
|
2012
|
16.00
|
|
2
|
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.
|
Eur J Heart Fail
|
2012
|
10.38
|
|
3
|
Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.
|
Eur Heart J
|
2007
|
6.34
|
|
4
|
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD).
|
Eur Heart J
|
2013
|
5.23
|
|
5
|
Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine.
|
Eur J Heart Fail
|
2010
|
2.64
|
|
6
|
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry.
|
Eur J Heart Fail
|
2013
|
1.53
|
|
7
|
Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
|
Circ Heart Fail
|
2009
|
1.43
|
|
8
|
2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS).
|
Eur Heart J
|
2015
|
1.42
|
|
9
|
2015 ESC Guidelines for the Diagnosis and Management of Pericardial Diseases.
|
Rev Esp Cardiol (Engl Ed)
|
2015
|
1.39
|
|
10
|
ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary.
|
Diab Vasc Dis Res
|
2014
|
1.10
|
|
11
|
Rationale and design of the COlchicine for Prevention of the Post-pericardiotomy Syndrome and Post-operative Atrial Fibrillation (COPPS-2 trial): a randomized, placebo-controlled, multicenter study on the use of colchicine for the primary prevention of the postpericardiotomy syndrome, postoperative effusions, and postoperative atrial fibrillation.
|
Am Heart J
|
2013
|
0.96
|
|
12
|
[2015 ESC Guidelines for the diagnosis and management of pericardial diseases].
|
Kardiol Pol
|
2015
|
0.89
|
|
13
|
[Not Available].
|
Turk Kardiyol Dern Ars
|
2012
|
0.79
|
|
14
|
Regional difference of microcirculation in patients with asymmetric hypertrophic cardiomyopathy: transthoracic Doppler coronary flow velocity reserve analysis.
|
J Am Soc Echocardiogr
|
2013
|
0.78
|
|
15
|
Diagnostic value of NT-proBNP in identifying impaired coronary flow reserve in asymptomatic moderate or severe aortic stenosis.
|
Biomark Med
|
2013
|
0.77
|
|
16
|
European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society.
|
Europace
|
2015
|
0.77
|
|
17
|
[2015 ESC Guidelines for the diagnosis and management of pericardial diseases. Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)].
|
G Ital Cardiol (Rome)
|
2015
|
0.75
|
|
18
|
[Classification of the cardiomyopathies].
|
Kardiol Pol
|
2008
|
0.75
|
|
19
|
[ESC guidelines on diabetes, pre-diabetes and diseases of the cardiovascular system developed in cooperation with the EASD].
|
Kardiol Pol
|
2013
|
0.75
|